Scarica l'app Stockscreener
17.80
0.85%
+0.15
MediWound Ltd Borsa (MDWD) Ultime notizie
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
Zacks Investment Research
Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High?
Zacks Investment Research
What Makes MediWound (MDWD) a Good Fit for 'Trend Investing'
Zacks Investment Research
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?
Zacks Investment Research
Marinus Pharmaceuticals (MRNS) Reports Q4 Loss, Lags Revenue Estimates
Zacks Investment Research
MediWound to Participate in Two Upcoming Investor Conferences
GlobeNewswire Inc.
Wall Street Analysts Think MediWound (MDWD) Could Surge 134.77%: Read This Before Placing a Bet
Zacks Investment Research
MediWound (MDWD): Strong Industry, Solid Earnings Estimate Revisions
Zacks Investment Research
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army
GlobeNewswire Inc.
MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
GlobeNewswire Inc.
Wall Street Analysts Believe MediWound (MDWD) Could Rally 171.79%: Here's is How to Trade
Zacks Investment Research
Does MediWound (MDWD) Have the Potential to Rally 223.05% as Wall Street Analysts Expect?
Zacks Investment Research
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update
GlobeNewswire Inc.
MediWound to Report Third Quarter 2023 Financial Results
GlobeNewswire Inc.
1.06%
1.27%
Capitalizzazione:
|
Volume (24 ore):